跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AB1
首页
药物
AB1
AB1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CB1 receptor modulators
申请人: COOPER MARTIN
优先权: 2006
CN
US
5 件公开
Antibodies to IL-6 and use thereof
申请人: GARCIA-MARTINEZ LEON
优先权: 2009
US
5 件公开
DRUG COMPOUNDS COMPRISING ALBUMIN-BINDING MOIETIES
申请人: ASCENDIS PHARMA AS
优先权: 2023
CN
EP
US
WO
4 件公开
Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
申请人: FERNANDEZ MOLINA LUIS ENRIQUE
优先权: 2001
CN
US
2 件公开
5-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase Inhibitors
申请人: IRM LLC
优先权: 2005
CN
US
2 件公开
Method of treating allergic asthma with antibodies to IL-6
申请人: ALDERBIO HOLDINGS LLC
优先权: 2010
CN
US
2 件公开
Light emitting device and production method thereof, and composition for light emitting device and production method thereof
申请人: SUMITOMO CHEMICAL CO
优先权: 2019
CN
US
2 件公开
Monoclonal antibodies and their use
申请人: ECKERT HELMUT
优先权: 2002
US
2 件公开
Compounds and compositions as protein kinase inhibitors
申请人: IRM LLC
优先权: 2004
US
2 件公开
Modulators of cb1 receptors
申请人: 7TM PHARMA AS
优先权: 2006
CN
2 件公开
第 1 / 7 页
上一页
下一页
药物
反馈